Proposed $400bn tie-up with Bristol Myers Squibb would create world’s fourth-largest drugmaker but analysts question rationale ...

British drug producer AstraZeneca announced a major agreement with US President Donald J. Trump's administration aimed at reducing the cost of prescription medicines for US patients while supporting ...

Add Yahoo as a preferred source to see more of our stories on Google. A view of a helmet with the AstraZeneca logo next to a bust of former U.S. President Abraham Lincoln on the day of an announcement ...

WILMINGTON, Del., February 02, 2026--(BUSINESS WIRE)--AstraZeneca today begins trading its ordinary shares on the New York Stock Exchange (NYSE) for the first time, enabling more US investors to ...

The boss of AstraZeneca (AZN.L) has confirmed plans to invest $50bn in the US by 2030, emphasising the importance of domestic manufacturing and research to ensure “health sovereignty” and supply chain ...

The drug, known as camizestrant, can be used in combination with other cancer medicines in patients who have a genetically ...

Add Yahoo as a preferred source to see more of our stories on Google. AstraZeneca has pulled Andexxa AstraZeneca has pulled its anticoagulant therapy, Andexxa (recombinant coagulation factor Xa), from ...

AstraZeneca said it received U.S. approval for a new hypertension treatment, getting the green light to launch a drug the U.K. pharmaceutical company expects to generate multibillion-dollar annual ...

US ACT on Health Equity contributions support AstraZeneca’s long-term ambition in health equity and total more than $18 million to date AstraZeneca has proudly awarded $3.4 million to nonprofit ...

September 2026Etcamah in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer Approval based on SERENA-6 Phase III trial results which showed combinat ...